Skip to main content
Erschienen in: Netherlands Heart Journal 4/2013

01.04.2013 | Original Article

Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients

verfasst von: K. Kraaier, A. H. Starrenburg, R. M. Verheggen, J. van der Palen, M. F. Scholten

Erschienen in: Netherlands Heart Journal | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Implantable cardioverter defibrillators (ICDs) are designed to deliver shocks or antitachycardia pacing (ATP) in the event of ventricular arrhythmias. During follow-up, some ICD recipients experience the sensation of ICD discharge in the absence of an actual discharge (phantom shock). The aim of this study was to evaluate the incidence and predictors of phantom shocks in ICD recipients.

Methods

Medical records of 629 consecutive patients with ischaemic or dilated cardiomyopathy and prior ICD implantation were studied.

Results

With a median follow-up of 35 months, phantom shocks were reported by 5.1 % of ICD recipients (5.7 % in the primary prevention group and 3.7 % for the secondary prevention group; p=NS). In the combined group of primary and secondary prevention, there were no significant predictors of the occurrence of phantom shocks. However, in the primary prevention group, phantom shocks were related to a history of atrial fibrillation (p=0.03) and NYHA class <III (p=0.05). In the secondary prevention group, there were no significant predictors for phantom shocks.

Conclusion

Phantom shocks occur in approximately 5 % of all ICD recipients. In primary prevention patients, a relation with a history of atrial fibrillation and NYHA class <III were significant predictors for the occurrence of phantom shocks. In the secondary prevention patients, no significant predictors were found.
Literatur
1.
Zurück zum Zitat Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–83.CrossRef Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–83.CrossRef
2.
Zurück zum Zitat Lee DS, Green LD, Liu PP, et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol. 2003;41(9):1573–82.CrossRef Lee DS, Green LD, Liu PP, et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol. 2003;41(9):1573–82.CrossRef
3.
Zurück zum Zitat Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37.CrossRef Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37.CrossRef
4.
Zurück zum Zitat Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(10):e385–484.CrossRef Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(10):e385–484.CrossRef
5.
Zurück zum Zitat van Welsenes GH, Borleffs CJ, van Rees JB, et al. Improvements in 25 years of implantable cardioverter defibrillator therapy. Neth Heart J. 2011;19(1):24–30.CrossRef van Welsenes GH, Borleffs CJ, van Rees JB, et al. Improvements in 25 years of implantable cardioverter defibrillator therapy. Neth Heart J. 2011;19(1):24–30.CrossRef
6.
Zurück zum Zitat Kowey PR, Marinchak RA, Rials SJ. Things that go bang in the night. N Engl J Med. 1992;327(26):1884.CrossRef Kowey PR, Marinchak RA, Rials SJ. Things that go bang in the night. N Engl J Med. 1992;327(26):1884.CrossRef
7.
Zurück zum Zitat Swygman CA, Link M, Cliff D, et al. Incidence of phantom shocks in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 1998;21:810. Ref Type: Abstract. Swygman CA, Link M, Cliff D, et al. Incidence of phantom shocks in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 1998;21:810. Ref Type: Abstract.
8.
Zurück zum Zitat Wojcicka M, Lewandowski M, Smolis-Bak E, et al. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators. Kardiol Pol. 2008;66(10):1050–8.PubMed Wojcicka M, Lewandowski M, Smolis-Bak E, et al. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators. Kardiol Pol. 2008;66(10):1050–8.PubMed
9.
Zurück zum Zitat Bhandari AK, Anderson JL, Gilbert EM, et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. Am Heart J. 1992;124(2):381–6.CrossRef Bhandari AK, Anderson JL, Gilbert EM, et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. Am Heart J. 1992;124(2):381–6.CrossRef
10.
Zurück zum Zitat Kang Y. Relation of atrial arrhythmia-related symptoms to health-related quality of life in patients with newly diagnosed atrial fibrillation: a community hospital-based cohort. Heart Lung. 2006;35(3):170–7.CrossRef Kang Y. Relation of atrial arrhythmia-related symptoms to health-related quality of life in patients with newly diagnosed atrial fibrillation: a community hospital-based cohort. Heart Lung. 2006;35(3):170–7.CrossRef
11.
Zurück zum Zitat Prudente LA, Reigle J, Bourguignon C, et al. Psychological indices and phantom shocks in patients with ICD. J Interv Card Electrophysiol. 2006;15(3):185–90.CrossRef Prudente LA, Reigle J, Bourguignon C, et al. Psychological indices and phantom shocks in patients with ICD. J Interv Card Electrophysiol. 2006;15(3):185–90.CrossRef
12.
Zurück zum Zitat van den Broek KC, Nyklicek I, van der Voort PH, et al. Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing Clin Electrophysiol. 2008;31(7):850–7.CrossRef van den Broek KC, Nyklicek I, van der Voort PH, et al. Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing Clin Electrophysiol. 2008;31(7):850–7.CrossRef
13.
Zurück zum Zitat Jacob S, Panaich SS, Zalawadiya SK, et al. Phantom shocks unmasked: clinical data and proposed mechanism of memory reactivation of past traumatic shocks in patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol. 2012;34(2):205–13.CrossRef Jacob S, Panaich SS, Zalawadiya SK, et al. Phantom shocks unmasked: clinical data and proposed mechanism of memory reactivation of past traumatic shocks in patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol. 2012;34(2):205–13.CrossRef
14.
Zurück zum Zitat Erdman RA, Pedersen SS. Clinical and scientific progress related to the interface between cardiology and psychology: lessons learned from 35 years of experience at the Thoraxcenter of the Erasmus Medical Center in Rotterdam. Neth Heart J. 2011;19(11):470–6.CrossRef Erdman RA, Pedersen SS. Clinical and scientific progress related to the interface between cardiology and psychology: lessons learned from 35 years of experience at the Thoraxcenter of the Erasmus Medical Center in Rotterdam. Neth Heart J. 2011;19(11):470–6.CrossRef
Metadaten
Titel
Incidence and predictors of phantom shocks in implantable cardioverter defibrillator recipients
verfasst von
K. Kraaier
A. H. Starrenburg
R. M. Verheggen
J. van der Palen
M. F. Scholten
Publikationsdatum
01.04.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Netherlands Heart Journal / Ausgabe 4/2013
Print ISSN: 1568-5888
Elektronische ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-012-0345-z

Weitere Artikel der Ausgabe 4/2013

Netherlands Heart Journal 4/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.